1
|
De Francesco S, Crema C, Archetti D, Muscio C, Reid RI, Nigri A, Bruzzone MG, Tagliavini F, Lodi R, D'Angelo E, Boeve B, Kantarci K, Firbank M, Taylor JP, Tiraboschi P, Redolfi A. Author Correction: Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. Sci Rep 2024; 14:1603. [PMID: 38238461 PMCID: PMC10796393 DOI: 10.1038/s41598-024-51435-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2024] Open
Affiliation(s)
- Silvia De Francesco
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
| | - Claudio Crema
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Damiano Archetti
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Cristina Muscio
- ASST Bergamo Ovest, Bergamo, Italy
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Robert I Reid
- Department of Information Technology, Mayo Clinic and Foundation, Rochester, Minnesota, USA
| | - Anna Nigri
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Maria Grazia Bruzzone
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Fabrizio Tagliavini
- Scientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Raffaele Lodi
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Egidio D'Angelo
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- IRCCS Mondino Foundation, Pavia, Italy
| | - Brad Boeve
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
| | - Kejal Kantarci
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
| | - Michael Firbank
- Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, UK
| | - John-Paul Taylor
- Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, UK
| | - Pietro Tiraboschi
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Alberto Redolfi
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| |
Collapse
|
2
|
De Francesco S, Crema C, Archetti D, Muscio C, Reid RI, Nigri A, Bruzzone MG, Tagliavini F, Lodi R, D'Angelo E, Boeve B, Kantarci K, Firbank M, Taylor JP, Tiraboschi P, Redolfi A. Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. Sci Rep 2023; 13:17355. [PMID: 37833302 PMCID: PMC10575864 DOI: 10.1038/s41598-023-43706-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 09/27/2023] [Indexed: 10/15/2023] Open
Abstract
Biomarker-based differential diagnosis of the most common forms of dementia is becoming increasingly important. Machine learning (ML) may be able to address this challenge. The aim of this study was to develop and interpret a ML algorithm capable of differentiating Alzheimer's dementia, frontotemporal dementia, dementia with Lewy bodies and cognitively normal control subjects based on sociodemographic, clinical, and magnetic resonance imaging (MRI) variables. 506 subjects from 5 databases were included. MRI images were processed with FreeSurfer, LPA, and TRACULA to obtain brain volumes and thicknesses, white matter lesions and diffusion metrics. MRI metrics were used in conjunction with clinical and demographic data to perform differential diagnosis based on a Support Vector Machine model called MUQUBIA (Multimodal Quantification of Brain whIte matter biomArkers). Age, gender, Clinical Dementia Rating (CDR) Dementia Staging Instrument, and 19 imaging features formed the best set of discriminative features. The predictive model performed with an overall Area Under the Curve of 98%, high overall precision (88%), recall (88%), and F1 scores (88%) in the test group, and good Label Ranking Average Precision score (0.95) in a subset of neuropathologically assessed patients. The results of MUQUBIA were explained by the SHapley Additive exPlanations (SHAP) method. The MUQUBIA algorithm successfully classified various dementias with good performance using cost-effective clinical and MRI information, and with independent validation, has the potential to assist physicians in their clinical diagnosis.
Collapse
Affiliation(s)
- Silvia De Francesco
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
| | - Claudio Crema
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Damiano Archetti
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Cristina Muscio
- ASST Bergamo Ovest, Bergamo, Italy
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Robert I Reid
- Department of Information Technology, Mayo Clinic and Foundation, Rochester, Minnesota, USA
| | - Anna Nigri
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Maria Grazia Bruzzone
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Fabrizio Tagliavini
- Scientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Raffaele Lodi
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Egidio D'Angelo
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- IRCCS Mondino Foundation, Pavia, Italy
| | - Brad Boeve
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
| | - Kejal Kantarci
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
| | - Michael Firbank
- Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, UK
| | - John-Paul Taylor
- Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle Upon Tyne, UK
| | - Pietro Tiraboschi
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Alberto Redolfi
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| |
Collapse
|
3
|
Conca F, Esposito V, Rundo F, Quaranta D, Muscio C, Manenti R, Caruso G, Lucca U, Galbussera AA, Di Tella S, Baglio F, L'Abbate F, Canu E, Catania V, Filippi M, Mattavelli G, Poletti B, Silani V, Lodi R, De Matteis M, Maserati MS, Arighi A, Rotondo E, Tanzilli A, Pace A, Garramone F, Cavaliere C, Pardini M, Rizzetto C, Sorbi S, Perri R, Tiraboschi P, Canessa N, Cotelli M, Ferri R, Weintraub S, Marra C, Tagliavini F, Catricalà E, Cappa SF. Correction: Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I‑UDSNB 1.0): development and normative data. Alzheimers Res Ther 2023; 15:104. [PMID: 37277846 DOI: 10.1186/s13195-023-01247-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
| | | | - Francesco Rundo
- Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy
| | - Davide Quaranta
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
- Department of Psychology, Catholic University of the Sacred Heart, Milan, Italy
| | - Cristina Muscio
- Present address: ASST Bergamo Ovest, Treviglio, Italy
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Rosa Manenti
- IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy
| | - Giulia Caruso
- Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Ugo Lucca
- Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - Alessia Antonella Galbussera
- Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | | | | | - Federica L'Abbate
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
| | - Elisa Canu
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Valentina Catania
- Unit of Psychology I.C., Oasi Research Institute-IRCCS, Troina, Italy
| | - Massimo Filippi
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
- Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Giulia Mattavelli
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy
| | - Barbara Poletti
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Vincenzo Silani
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Università Degli Studi Di Milano, Milan, Italy
| | - Raffaele Lodi
- IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy
| | | | | | - Andrea Arighi
- Fondazione IRCSS Ca' Granda, Ospedale Policlinico, Milan, Italy
| | | | - Antonio Tanzilli
- Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Andrea Pace
- Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | | | | | - Matteo Pardini
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
| | - Cristiano Rizzetto
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
| | - Sandro Sorbi
- IRCCS Fondazione Don Carlo Gnocchi, ONLUS, Milan, Italy
| | - Roberta Perri
- Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | | | - Nicola Canessa
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy
| | - Maria Cotelli
- IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy
| | - Raffaele Ferri
- Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy
| | - Sandra Weintraub
- Mesulam Center for Cognitive Neurology and Alzheimer's Disease and Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Department of Neurology, Northwestern University, Chicago, IL, USA
| | - Camillo Marra
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
| | | | - Eleonora Catricalà
- IRCCS Mondino Foundation, Pavia, Italy
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
| | - Stefano Francesco Cappa
- IRCCS Mondino Foundation, Pavia, Italy.
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy.
| |
Collapse
|
4
|
Conca F, Esposito V, Rundo F, Quaranta D, Muscio C, Manenti R, Caruso G, Lucca U, Galbussera AA, Di Tella S, Baglio F, L'Abbate F, Canu E, Catania V, Filippi M, Mattavelli G, Poletti B, Silani V, Lodi R, De Matteis M, Maserati MS, Arighi A, Rotondo E, Tanzilli A, Pace A, Garramone F, Cavaliere C, Pardini M, Rizzetto C, Sorbi S, Perri R, Tiraboschi P, Canessa N, Cotelli M, Ferri R, Weintraub S, Marra C, Tagliavini F, Catricalà E, Cappa SF. Correction: Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I‑UDSNB 1.0): development and normative data. Alzheimers Res Ther 2023; 15:63. [PMID: 36964616 PMCID: PMC10037826 DOI: 10.1186/s13195-023-01213-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/26/2023]
Affiliation(s)
| | | | - Francesco Rundo
- Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy
| | - Davide Quaranta
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
- Department of Psychology, Catholic University of the Sacred Heart, Milan, Italy
| | - Cristina Muscio
- Present address: ASST Bergamo Ovest, Treviglio, Italy
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Rosa Manenti
- IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy
| | - Giulia Caruso
- Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Ugo Lucca
- Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - Alessia Antonella Galbussera
- Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | | | | | - Federica L'Abbate
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
| | - Elisa Canu
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Valentina Catania
- Unit of Psychology I.C., Oasi Research Institute-IRCCS, Troina, Italy
| | - Massimo Filippi
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
- Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Giulia Mattavelli
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy
| | - Barbara Poletti
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Vincenzo Silani
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Università Degli Studi Di Milano, Milan, Italy
- Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università Degli Studi Di Milano, Milan, Italy
| | - Raffaele Lodi
- IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy
| | | | | | - Andrea Arighi
- Fondazione IRCSS ca' Granda, Ospedale Policlinico, Milan, Italy
| | | | - Antonio Tanzilli
- Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Andrea Pace
- Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | | | | | - Matteo Pardini
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
| | - Cristiano Rizzetto
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
| | - Sandro Sorbi
- IRCCS Fondazione Don Carlo Gnocchi, ONLUS, Milan, Italy
| | - Roberta Perri
- Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | | | - Nicola Canessa
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy
| | - Maria Cotelli
- IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy
| | - Raffaele Ferri
- Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy
| | - Sandra Weintraub
- Mesulam Center for Cognitive Neurology and Alzheimer's Disease and Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Department of Neurology, Northwestern University, Chicago, IL, USA
| | - Camillo Marra
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
| | | | - Eleonora Catricalà
- IRCCS Mondino Foundation, Pavia, Italy
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
| | - Stefano Francesco Cappa
- IRCCS Mondino Foundation, Pavia, Italy.
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy.
| |
Collapse
|
5
|
Verde F, Aiello EN, Adobbati L, Poletti B, Solca F, Tiloca C, Sangalli D, Maranzano A, Muscio C, Ratti A, Zago S, Ticozzi N, Frisoni GB, Silani V. Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature. J Alzheimers Dis 2023; 95:1383-1399. [PMID: 37694369 DOI: 10.3233/jad-230562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/12/2023]
Abstract
We describe a case of amyotrophic lateral sclerosis (ALS) associated with Alzheimer's disease (AD) and review the literature about the coexistence of the two entities, highlighting the following: mean age at onset is 63.8 years, with slight female predominance; ALS tends to manifest after cognitive impairment and often begins in the bulbar region; average disease duration is 3 years; cognitive phenotype is mostly amnestic; the pattern of brain involvement is, in most cases, consistent with AD. Our case and the reviewed ones suggest that patients with ALS and dementia lacking unequivocal features of FTD should undergo additional examinations in order to recognize AD.
Collapse
Affiliation(s)
- Federico Verde
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy
| | - Edoardo Nicolò Aiello
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Laura Adobbati
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Barbara Poletti
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy
| | - Federica Solca
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Cinzia Tiloca
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Davide Sangalli
- Department of Neurology and Stroke Unit, Azienda Socio Sanitaria Territoriale Lecco, Lecco, Italy
| | - Alessio Maranzano
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Cristina Muscio
- Neurology-5 (Neuropathology) Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Antonia Ratti
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy
| | - Stefano Zago
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Nicola Ticozzi
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy
| | - Giovanni Battista Frisoni
- Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland
| | - Vincenzo Silani
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy
| |
Collapse
|
6
|
Lombardi G, Chipi E, Arenella D, Fiorani A, Frisoni GB, Linarello S, Montanucci C, Muscio C, Pacifico I, Pelizzari S, Perani D, Piras F, Rozzini L, Sorbi S, Spalletta G, Tagliavini F, Tiraboschi P, Parnetti L, Filippini G. Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study. Front Psychiatry 2022; 13:1050583. [PMID: 36506451 PMCID: PMC9731677 DOI: 10.3389/fpsyt.2022.1050583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Accepted: 11/01/2022] [Indexed: 11/25/2022] Open
Abstract
Introduction Timely detection of cognitive decline in primary care is essential to promote an appropriate care pathway and enhance the benefits of interventions. We present the results of a study aimed to evaluate the effectiveness of an educational intervention addressed to Italian family physicians (FPs) to improve timely detection and management of cognitive decline. Materials and methods We conducted a pre-post study in six Italian health authorities (HAs) involving 254 FPs and 3,736 patients. We measured process and outcome indicators before the intervention (1 January 2014 to 31 December 2016) and after the intervention (1 January 2018 to 31 December 2019). One interactive face-to-face session workshop was delivered by local cognitive disorders and dementia specialists and FP advisors at each HA, in the period September 2017-December 2017. The session focused on key messages of the local Diagnostic and Therapeutic Care Pathway (DTCP) or regional guidelines: (a) the role of the FP for a timely suspicion of cognitive decline is fundamental; (b) when cognitive decline is suspected, the role of the FP is active in the diagnostic work-up; (c) FP's knowledge on pharmacological and non-pharmacological interventions is essential to improve the management of patients with cognitive decline. Results An overall improvement in diagnostic procedures and management of patients with cognitive decline by FPs after the intervention was observed. The number of visits per year performed by FPs increased, and the time interval between the first FP consultation and the diagnosis was optimized. Neuroleptic use significantly decreased, whereas the use of benzodiazepines remained steadily high. Non-pharmacological interventions, or use of support services, were underrepresented even in the post-intervention. Differences among the participating HAs were identified and discussed. Discussion Results from this study suggest the success of the educational intervention addressed to FPs in improving early detection and management of cognitive decline, highlighting the importance to continue medical education in this field. At the same time, further initiatives of care pathway dissemination and implementation should promote strategies to enhance interactions between primary and secondary care optimizing the collaboration between FPs and specialists.
Collapse
Affiliation(s)
| | - Elena Chipi
- Centre for Memory Disturbances, Section of Neurology, Lab of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
| | | | - Ambra Fiorani
- Laboratory of Neurology, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - Giovanni Battista Frisoni
- Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio - Fatebenefratelli, Brescia, Italy
- Memory Clinic, Geneva University Hospitals, Geneva, Switzerland
| | | | - Chiara Montanucci
- Centre for Memory Disturbances, Section of Neurology, Lab of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
| | - Cristina Muscio
- ASST Bergamo Ovest - Azienda Socio Sanitaria Territoriale di Bergamo Ovest, Bergamo, Italy
| | - Irene Pacifico
- Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Silvia Pelizzari
- Centro per i Disturbi Cognitivi e le Demenze, Spedali Civili di Brescia, Brescia, Italy
| | - Daniela Perani
- Division of Neuroscience, San Raffaele Scientific Institute, San Raffaele University, Milan, Italy
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Luca Rozzini
- Centro per i Disturbi Cognitivi e le Demenze, Spedali Civili di Brescia, Brescia, Italy
| | - Sandro Sorbi
- IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy
- Section of Psychology - Department of Neuroscience, Psychology, Drug Research and Child’s Health (NEUROFARBA), University of Florence, Florence, Italy
| | - Gianfranco Spalletta
- Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
- Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States
| | | | | | - Lucilla Parnetti
- Centre for Memory Disturbances, Section of Neurology, Lab of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
| | | |
Collapse
|
7
|
Conca F, Esposito V, Rundo F, Quaranta D, Muscio C, Manenti R, Caruso G, Lucca U, Galbussera AA, Di Tella S, Baglio F, L'Abbate F, Canu E, Catania V, Filippi M, Mattavelli G, Poletti B, Silani V, Lodi R, De Matteis M, Stanzani Maserati M, Arighi A, Rotondo E, Tanzilli A, Pace A, Garramone F, Cavaliere C, Pardini M, Rizzetto C, Sorbi S, Perri R, Tiraboschi P, Canessa N, Cotelli M, Ferri R, Weintraub S, Marra C, Tagliavini F, Catricalà E, Cappa SF. Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data. Alzheimers Res Ther 2022; 14:113. [PMID: 35982477 PMCID: PMC9389755 DOI: 10.1186/s13195-022-01056-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2022] [Accepted: 07/18/2022] [Indexed: 11/17/2022]
Abstract
BACKGROUND Neuropsychological testing plays a cardinal role in the diagnosis and monitoring of Alzheimer's disease. A major concern is represented by the heterogeneity of the neuropsychological batteries currently adopted in memory clinics and healthcare centers. The current study aimed to solve this issue. METHODS Following the initiative of the University of Washington's National Alzheimer's Coordinating Center (NACC), we presented the Italian adaptation of the Neuropsychological Test Battery of the Uniform Data Set (I-UDSNB). We collected data from 433 healthy Italian individuals and employed regression models to evaluate the impact of demographic variables on the performance, deriving the reference norms. RESULTS Higher education and lower age were associated with a better performance in the majority of tests, while sex affected only fluency tests and Digit Span Forward. CONCLUSIONS The I-UDSNB offers a valuable and harmonized tool for neuropsychological testing in Italy, to be used in clinical and research settings.
Collapse
Affiliation(s)
| | | | - Francesco Rundo
- Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy
| | - Davide Quaranta
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
- Department of Psychology, Catholic University of the Sacred Heart, Milan, Italy
| | - Cristina Muscio
- Present address: ASST Bergamo Ovest, Treviglio, Italy
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Rosa Manenti
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Giulia Caruso
- Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Ugo Lucca
- Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | - Alessia Antonella Galbussera
- Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | | | | | - Federica L'Abbate
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
| | - Elisa Canu
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Valentina Catania
- Unit of Psychology I.C., Oasi Research Institute-IRCCS, Troina, Italy
| | - Massimo Filippi
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
- Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
| | - Giulia Mattavelli
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy
| | - Barbara Poletti
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
| | - Vincenzo Silani
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy
- Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Università degli studi di Milano, Milan, Italy
- Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli studi di Milano, Milan, Italy
| | - Raffaele Lodi
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
| | | | | | - Andrea Arighi
- Fondazione IRCSS ca' Granda, Ospedale Policlinico, Milan, Italy
| | | | - Antonio Tanzilli
- Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | - Andrea Pace
- Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
| | | | | | - Matteo Pardini
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
| | - Cristiano Rizzetto
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy
| | - Sandro Sorbi
- IRCCS Fondazione Don Carlo Gnocchi, ONLUS, Milan, Italy
| | - Roberta Perri
- Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | | | - Nicola Canessa
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy
| | - Maria Cotelli
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Raffaele Ferri
- Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy
| | - Sandra Weintraub
- Mesulam Center for Cognitive Neurology and Alzheimer's Disease and Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Department of Neurology, Northwestern University, Chicago, IL, USA
| | - Camillo Marra
- Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
| | | | - Eleonora Catricalà
- IRCCS Mondino Foundation, Pavia, Italy
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy
| | - Stefano Francesco Cappa
- IRCCS Mondino Foundation, Pavia, Italy.
- IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy.
| |
Collapse
|
8
|
Tondo G, Boccalini C, Vanoli EG, Presotto L, Muscio C, Ciullo V, Banaj N, Piras F, Filippini G, Tiraboschi P, Tagliavini F, Frisoni GB, Cappa SF, Spalletta G, Perani D. Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment. Neurology 2022; 99:e258-e269. [PMID: 35487700 PMCID: PMC9302934 DOI: 10.1212/wnl.0000000000200351] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Accepted: 02/21/2022] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND AND OBJECTIVE This was a multicenter study aimed at investigating the characteristics of cognitive decline, neuropsychiatric symptoms, and brain imaging in individuals with subjective cognitive decline (SCD) and subtle cognitive decline (pre-mild cognitive impairment [pre-MCI]). METHODS Data were obtained from the Network-AD project (NET-2011-02346784). The included participants underwent baseline cognitive and neurobehavioral evaluation, FDG-PET, and amyloid PET. We used principal component analysis (PCA) to identify independent neuropsychological and neuropsychiatric dimensions and their association with brain metabolism. RESULTS A total of 105 participants (SCD = 49, pre-MCI = 56) were included. FDG-PET was normal in 45% of participants and revealed brain hypometabolism in 55%, with a frontal-like pattern as the most frequent finding (28%). Neuropsychiatric symptoms emerging from the Neuropsychiatric Inventory and the Starkstein Apathy Scale were highly prevalent in the whole sample (78%). An abnormal amyloid load was detected in the 18% of the participants who underwent amyloid PET (n = 60). PCA resulted in 3 neuropsychological factors: (1) executive/visuomotor, correlating with hypometabolism in frontal and occipital cortices and basal ganglia; (2) memory, correlating with hypometabolism in temporoparietal regions; and (3) visuospatial/constructional, correlating with hypometabolism in frontoparietal cortices. Two factors emerged from the neuropsychiatric PCA: (1) affective, correlating with hypometabolism in orbitofrontal and cingulate cortex and insula; (2) hyperactive/psychotic, correlating with hypometabolism in frontal, temporal, and parietal regions. DISCUSSION FDG-PET evidence suggests either normal brain function or different patterns of brain hypometabolism in SCD and pre-MCI. These results indicate that SCD and pre-MCI represent heterogeneous populations. Different neuropsychological and neuropsychiatric profiles emerged, which correlated with neuronal dysfunction in specific brain regions. Long-term follow-up studies are needed to assess the risk of progression to dementia in these conditions.
Collapse
Affiliation(s)
- Giacomo Tondo
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Cecilia Boccalini
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Emilia Giovanna Vanoli
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Luca Presotto
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Cristina Muscio
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Valentina Ciullo
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Nerisa Banaj
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Federica Piras
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Graziella Filippini
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Pietro Tiraboschi
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Fabrizio Tagliavini
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Giovanni Battista Frisoni
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Stefano F Cappa
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Gianfranco Spalletta
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy
| | - Daniela Perani
- From Vita-Salute San Raffaele University (G.T., C.B., D.P.); In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience (G.T., C.B., L.P., D.P.), IRCCS San Raffaele Scientific Institute; Nuclear Medicine Unit (E.G.V., L.P., D.P.), San Raffaele Hospital; Unit of Neurology and Neuropathology (P.T.), Fondazione IRCCS Istituto Neurologico Carlo Besta (C.M., G.F., F.T.), Milan; Laboratory of Neuropsychiatry (V.C., N.B., F.P., G.S.), IRCCS Santa Lucia Foundation, Rome; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (G.B.F.), Brescia, Italy; Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging (G.B.F.), University Hospitals and University of Geneva, Switzerland; ICoN (S.F.C.), Scuola Universitaria Superiore IUSS Pavia; and IRCCS Mondino Foundation (S.F.C.), Pavia, Italy.
| |
Collapse
|
9
|
Russo M, Carrarini C, Di Iorio A, Pellegrino R, Bruni AC, Caratozzolo S, Chiari A, Pretta S, Marra C, Cotelli MS, Arighi A, Fumagalli GG, Cataruzza T, Caso F, Paci C, Rosso M, Amici S, Giannandrea D, Pilotto A, Luzzi S, Castellano A, D'antonio F, Luca A, Gelosa G, Piccoli T, Mauri M, Agosta F, Babiloni C, Borroni B, Bozzali M, Filippi M, Galimberti D, Monastero R, Muscio C, Parnetti L, Perani D, Serra L, Silani V, Tiraboschi P, Cagnin A, Padovani A, Bonanni L. Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem). Neurol Sci 2022; 43:4221-4229. [PMID: 35244829 PMCID: PMC9213280 DOI: 10.1007/s10072-022-05987-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Accepted: 02/25/2022] [Indexed: 11/25/2022]
Abstract
Introduction Dementia with Lewy bodies (DLB) may represent a diagnostic challenge, since its clinical picture overlaps with other dementia. Two toolkits have been developed to aid the clinician to diagnose DLB: the Lewy Body Composite Risk Score (LBCRS) and the Assessment Toolkit for DLB (AT-DLB). We aim to evaluate the reliability of these two questionnaires, and their ability to enhance the interpretation of the international consensus diagnostic criteria. Methods LBCRS and AT-DLB were distributed to 135 Italian Neurological Centers for Cognitive Decline and Dementia (CDCDs), with the indication to administer them to all patients with dementia referred within the subsequent 3 months. We asked to subsequently apply consensus criteria for DLB diagnosis, to validate the diagnostic accuracy of the two toolkits. Results A total of 23 Centers joined the study; 1854 patients were enrolled. We found a prevalence of possible or probable DLB of 13% each (26% total), according to the consensus criteria. LBCRS toolkit showed good reliability, with a Cronbach alpha of 0.77, stable even after removing variables from the construct. AT-DLB toolkit Cronbach alpha was 0.52 and, after the subtraction of the “cognitive fluctuation” criterion, was only 0.31. Accuracy, sensitivity, and specificity were higher for LBCRS vs. AT-DLB. However, when simultaneously considered in the logistic models, AT-DLB showed a better performance (p < 0.001). Overall, the concordance between LBCRS positive and AT-DLB possible/probable was of 78.02% Conclusions In a clinical setting, the LBCRS and AT-DLB questionnaires have good accuracy for DLB diagnosis. Supplementary Information The online version contains supplementary material available at 10.1007/s10072-022-05987-z.
Collapse
Affiliation(s)
- Mirella Russo
- Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - Claudia Carrarini
- Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - Angelo Di Iorio
- Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - Raffaello Pellegrino
- Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - Amalia Cecilia Bruni
- Regional Neurogenetic Centre, Department of Primary Care, ASP-CZ, Lamezia Terme, Italy
| | - Salvatore Caratozzolo
- Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Annalisa Chiari
- U.O. Di Neurologia, Azienda Ospedaliera Universitaria Di Modena, Modena, Italy
| | - Stefano Pretta
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Camillo Marra
- Memory Clinic, Fondazione Policlinico Gemelli, IRCCS Università, Cattolica del Sacro Cuore, Rome, Italy
| | | | - Andrea Arighi
- UOSD Neurologia, Malattie Neurodegenerative, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
| | - Giorgio G Fumagalli
- UOSD Neurologia, Malattie Neurodegenerative, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
| | - Tatiana Cataruzza
- Department of Medicine, Surgery and Health Sciences, Neurology Unit, University Hospital and Health Services of Trieste, Trieste, Italy
| | - Francesca Caso
- Unit of Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Cristina Paci
- Division of Neurology, Ospedale Madonna del Soccorso, ASUR Marche, San Benedetto del Tronto-Ascoli, Piceno, Italy
| | - Mara Rosso
- Neurology Clinic, SS Annunziata Hospital of Savigliano, Savigliano, Italy
| | - Serena Amici
- Cognitive Disorder and Dementia Unit, USL Umbria 1, Perugia, Italy
| | - David Giannandrea
- Neurologia E Stroke Unit, Ospedale Di Gubbio E Gualdo Tadino, Perugia, Italy
| | - Andrea Pilotto
- Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Simona Luzzi
- Department of Experimental and Clinical Medicine, Polytechnic University of Marche - Ospedali Riuniti, Ancona, Italy
| | | | - Fabrizia D'antonio
- Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy
| | - Antonina Luca
- Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy
| | - Giorgio Gelosa
- Cognitive Neuropsychology Center, Niguarda Hospital, Milan, Italy
| | - Tommaso Piccoli
- Unit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy
| | - Marco Mauri
- Department of Biotechnologies and Life Sciences, University of Insubria, Varese, Italy
| | - Federica Agosta
- Unit of Neurology, Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy
| | - Claudio Babiloni
- Department of Physiology and Pharmacology "V. Erspamer, Sapienza University of Rome, Rome, Italy
- Hospital San Raffaele Cassino (FR), Cassino, Italy
| | - Barbara Borroni
- Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Marco Bozzali
- Department of Neuroscience, University of Turin, Turin, Italy
| | - Massimo Filippi
- Unit of Neurology, Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy
| | - Daniela Galimberti
- UOSD Neurologia, Malattie Neurodegenerative, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
| | - Roberto Monastero
- Section of Neurology, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy
| | - Cristina Muscio
- Neurology 5-Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Lucilla Parnetti
- Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy
| | - Daniela Perani
- In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Laura Serra
- Neuroimaging Laboratory, Fondazione Santa Lucia, IRCCS, Rome, Italy
| | - Vincenzo Silani
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano and Università Degli Studi Di Milano, Milano, Italy
| | - Pietro Tiraboschi
- Neurology 5-Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Alessandro Padovani
- Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Laura Bonanni
- Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.
| |
Collapse
|
10
|
Galluzzi S, Mega A, Di Fede G, Muscio C, Fascendini S, Benussi L, Tagliavini F, Frisoni GB, Di Maria E. Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia: The IT-DIAfN Protocol. Alzheimer Dis Assoc Disord 2022; 36:118-124. [PMID: 35293381 PMCID: PMC9132242 DOI: 10.1097/wad.0000000000000494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Accepted: 12/22/2021] [Indexed: 11/26/2022]
Abstract
AIM Our aim was to evaluate the psychological impact of predictive genetic testing in individuals at-risk for inherited dementia who underwent a structured counseling and testing protocol. METHODS Participants were healthy at-risk relatives from families with at least one affected patient, in whom a disease-associated genetic variant had been ascertained. A comprehensive psychological assessment (personality, anxiety and depression, quality of life, coping strategies, resilience and health-related beliefs) was administered at baseline, at 6 months and 12 months follow-up. RESULTS Twenty-four participants from 13 families were included. Sixteen participants underwent blood sampling and genetic analysis; 6 resulted to be carriers of pathogenic variants (1 in PSEN1, 1 in PSEN2, 4 in GRN). Carriers showed higher score on the Resilience Scale for Adults (RSA) - social competence, and on Multidimensional Health Locus of Control - internal, than noncarriers (P=0.03 for both). Ten at-risk relatives who completed the follow-up showed improvement in RSA - planned future (P=0.01) with respect to baseline. DISCUSSION Our case series showed that at-risk individuals undergoing predictive testing showed benefit on personal life and no detrimental impact on a broad range of psychological outcomes. Higher social skills and lower internal health locus of control in carriers may be an early psychological correlate of preclinical dementia.
Collapse
Affiliation(s)
| | - Anna Mega
- Laboratory Alzheimer’s Neuroimaging and Epidemiology
| | - Giuseppe Di Fede
- Neurology V – Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano
| | - Cristina Muscio
- Neurology V – Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano
| | | | - Luisa Benussi
- Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia
| | - Fabrizio Tagliavini
- Scientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano
| | | | - Giovanni B. Frisoni
- Laboratory Alzheimer’s Neuroimaging and Epidemiology
- Memory Clinic, Department of Rehabilitation and Geriatrics, University Hospitals and University of Geneva, Genève, Switzerland
| | - Emilio Di Maria
- Department of Health Sciences, University of Genoa
- Unit of Medical Genetics, Galliera Hospital, Genoa
| |
Collapse
|
11
|
Tondo G, Boccalini C, Luca P, Muscio C, Tagliavini F, Ciullo V, Piras F, Cappa S, Spalletta G, Perani D. Brain metabolism, amyloid load and neuropsychological correlates in preclinical dementia stages. J Neurol Sci 2021. [DOI: 10.1016/j.jns.2021.117825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Russo M, Carrarini C, Di Iorio A, Ferri L, De Rosa M, Calisi D, Consoli S, Dono F, Cagnin A, Agosta F, Babiloni C, Borroni B, Bozzali M, Bruni A, Filippi M, Galimberti D, Monastero R, Muscio C, Parnetti L, Perani D, Serra L, Silani V, Tiraboschi P, Onofrj M, Padovani A, Bonanni L. The Italian dementia with lewy bodies study group (DLB-SINDEM): A multicenter survey on the accuracy and the prevalence of DLB diagnosis. J Neurol Sci 2021. [DOI: 10.1016/j.jns.2021.117651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
13
|
Tiraboschi P, Xhani R, Zerbi SM, Corso A, Martinelli I, Fusi L, Grampa G, Lombardo A, Cavalcante P, Cappelletti C, Andreetta F, Sironi A, Redolfi A, Muscio C. Postinfectious Neurologic Complications in COVID-19: A Complex Case Report. J Nucl Med 2021; 62:1171-1176. [PMID: 34016729 PMCID: PMC8833873 DOI: 10.2967/jnumed.120.256099] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Accepted: 03/09/2021] [Indexed: 02/02/2023] Open
Abstract
A 40-y-old woman with severe acute respiratory syndrome coronavirus 2 infection developed neurologic manifestations (confusion, agitation, seizures, dyskinesias, and parkinsonism) a few weeks after the onset of severe acute respiratory syndrome. MRI and cerebrospinal fluid analyses were unremarkable, but 18F-FDG PET/CT showed limbic and extralimbic hypermetabolism. A full recovery, alongside 18F-FDG normalization in previously hypermetabolic areas, was observed after intravenous immunoglobulin administration.
Collapse
Affiliation(s)
- Pietro Tiraboschi
- Neurology 5-Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy;
| | - Rubjona Xhani
- Neurology Department of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Simone M Zerbi
- Intensive Care Unit of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Angelo Corso
- Nuclear Medicine Department of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Isabella Martinelli
- Nuclear Medicine Department of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Laura Fusi
- Neurology Department of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Giampiero Grampa
- Neurology Department of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Andrea Lombardo
- Intensive Care Unit of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy
| | - Paola Cavalcante
- Neurology 4-Neuroimmunology and Neuromuscular Disease Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Cristina Cappelletti
- Neurology 4-Neuroimmunology and Neuromuscular Disease Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Francesca Andreetta
- Neurology 4-Neuroimmunology and Neuromuscular Disease Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Alberto Sironi
- Radiology Department of ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia, Italy; and
| | - Alberto Redolfi
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Cristina Muscio
- Neurology 5-Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| |
Collapse
|
14
|
Pareyson D, Pantaleoni C, Eleopra R, De Filippis G, Moroni I, Freri E, Zibordi F, Bulgheroni S, Pagliano E, Sarti D, Silvani A, Grazzi L, Tiraboschi P, Didato G, Anghileri E, Bersano A, Valentini L, Piacentini S, Muscio C, Leonardi M, Mariotti C, Eoli M, Nuzzo S, Tagliavini F, Confalonieri P, De Giorgi F. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurol Sci 2021; 42:2637-2644. [PMID: 33929645 PMCID: PMC8086222 DOI: 10.1007/s10072-021-05252-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Accepted: 04/10/2021] [Indexed: 12/20/2022]
Abstract
Background Lombardy was severely hit by the COVID-19 pandemic since February 2020 and the Health System underwent rapid reorganization. Outpatient clinics were stopped for non-urgent patients: it became a priority to manage hundreds of fragile neurological patients who suddenly had less reference points. In Italy, before the pandemic, Televisits were neither recognized nor priced. Methods At the Fondazione IRCCS Istituto Neurologico C. Besta, we reorganized outpatient clinics to deliver Neuro-telemedicine services, including Televisits and Teleneurorehabilitation, since March 2020. A dedicated Working Group prepared the procedure, tested the system, and designed satisfaction questionnaires for adults and children. Results After a pilot phase, we prepared a procedure for Telemedicine outpatient clinics which was approved by hospital directions. It included prescription, booking, consenting, privacy and data protection, secure connection with patients (Teams Microsoft 365), electronic report preparation and delivery, reporting, and accountability of the services. During the March–September 2020 period, we delivered 3167 Telemedicine services, including 1618 Televisits, to 1694 patients (972 adults, 722 children) with a wide range of chronic neurological disorders. We successfully administered different clinical assessment and scales. Satisfaction among patients and caregivers was very high. Conclusions During the dramatic emergency, we were able to take care of more than 1600 patients by organizing Neuro-telehealth in a few weeks, lessening the impact of the pandemic on fragile patients with chronic neurological disorders; this strategy is now stably embedded in our care pathways. In Italy, Telehealth is at present recognized and priced and is becoming a stable pillar of the health system.
Collapse
Affiliation(s)
- Davide Pareyson
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. .,Rare Neurodegenerative and Neurometabolic Diseases Unit, Clinical Neurosciences Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy.
| | | | - Roberto Eleopra
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Isabella Moroni
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Elena Freri
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Sara Bulgheroni
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Daniela Sarti
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Antonio Silvani
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Licia Grazzi
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Giuseppe Didato
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Elena Anghileri
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Anna Bersano
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Laura Valentini
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Cristina Muscio
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | | | - Marica Eoli
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Sara Nuzzo
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | | | | | | |
Collapse
|
15
|
Redolfi A, De Francesco S, Palesi F, Galluzzi S, Muscio C, Castellazzi G, Tiraboschi P, Savini G, Nigri A, Bottini G, Bruzzone MG, Ramusino MC, Ferraro S, Gandini Wheeler-Kingshott CAM, Tagliavini F, Frisoni GB, Ryvlin P, Demonet JF, Kherif F, Cappa SF, D'Angelo E. Medical Informatics Platform (MIP): A Pilot Study Across Clinical Italian Cohorts. Front Neurol 2020; 11:1021. [PMID: 33071930 PMCID: PMC7538836 DOI: 10.3389/fneur.2020.01021] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2020] [Accepted: 08/04/2020] [Indexed: 12/13/2022] Open
Abstract
Introduction: With the shift of research focus to personalized medicine in Alzheimer's Dementia (AD), there is an urgent need for tools that are capable of quantifying a patient's risk using diagnostic biomarkers. The Medical Informatics Platform (MIP) is a distributed e-infrastructure federating large amounts of data coupled with machine-learning (ML) algorithms and statistical models to define the biological signature of the disease. The present study assessed (i) the accuracy of two ML algorithms, i.e., supervised Gradient Boosting (GB) and semi-unsupervised 3C strategy (Categorize, Cluster, Classify-CCC) implemented in the MIP and (ii) their contribution over the standard diagnostic workup. Methods: We examined individuals coming from the MIP installed across 3 Italian memory clinics, including subjects with Normal Cognition (CN, n = 432), Mild Cognitive Impairment (MCI, n = 456), and AD (n = 451). The GB classifier was applied to best discriminate the three diagnostic classes in 1,339 subjects, and the CCC strategy was used to refine the classical disease categories. Four dementia experts provided their diagnostic confidence (DC) of MCI conversion on an independent cohort of 38 patients. DC was based on clinical, neuropsychological, CSF, and structural MRI information and again with addition of the outcome from the MIP tools. Results: The GB algorithm provided a classification accuracy of 85% in a nested 10-fold cross-validation for CN vs. MCI vs. AD discrimination. Accuracy increased to 95% in the holdout validation, with the omission of each Italian clinical cohort out in turn. CCC identified five homogeneous clusters of subjects and 36 biomarkers that represented the disease fingerprint. In the DC assessment, CCC defined six clusters in the MCI population used to train the algorithm and 29 biomarkers to improve patients staging. GB and CCC showed a significant impact, evaluated as +5.99% of increment on physicians' DC. The influence of MIP on DC was rated from "slight" to "significant" in 80% of the cases. Discussion: GB provided fair results in classification of CN, MCI, and AD. CCC identified homogeneous and promising classes of subjects via its semi-unsupervised approach. We measured the effect of the MIP on the physician's DC. Our results pave the way for the establishment of a new paradigm for ML discrimination of patients who will or will not convert to AD, a clinical priority for neurology.
Collapse
Affiliation(s)
- Alberto Redolfi
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Silvia De Francesco
- Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Fulvia Palesi
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- IRCCS Mondino Foundation, Pavia, Italy
| | - Samantha Galluzzi
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Cristina Muscio
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Gloria Castellazzi
- IRCCS Mondino Foundation, Pavia, Italy
- NMR Research Unit, Queen Square MS Center, Department of Neuroinflammation, UCL Institute of Neurology, London, United Kingdom
- Department of Computer, Electrical and Biomedical Engineering, University of Pavia, Pavia, Italy
| | - Pietro Tiraboschi
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | | | - Anna Nigri
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Gabriella Bottini
- Neuropsychology Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - Maria Grazia Bruzzone
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Matteo Cotta Ramusino
- IRCCS Mondino Foundation, Pavia, Italy
- Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland
| | - Stefania Ferraro
- Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Claudia A. M. Gandini Wheeler-Kingshott
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- IRCCS Mondino Foundation, Pavia, Italy
- NMR Research Unit, Queen Square MS Center, Department of Neuroinflammation, UCL Institute of Neurology, London, United Kingdom
| | - Fabrizio Tagliavini
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Giovanni B. Frisoni
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
- Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland
| | - Philippe Ryvlin
- Department of Clinical Neurosciences, Leenaards Memory Center, Center Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Jean-François Demonet
- Department of Clinical Neurosciences, Leenaards Memory Center, Center Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Ferath Kherif
- Department of Clinical Neurosciences, Leenaards Memory Center, Center Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Stefano F. Cappa
- IRCCS Mondino Foundation, Pavia, Italy
- University School of Advanced Studies, Pavia, Italy
| | - Egidio D'Angelo
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- IRCCS Mondino Foundation, Pavia, Italy
| |
Collapse
|
16
|
McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 2020; 94:743-755. [PMID: 32241955 PMCID: PMC7274845 DOI: 10.1212/wnl.0000000000009323] [Citation(s) in RCA: 319] [Impact Index Per Article: 79.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Accepted: 02/25/2020] [Indexed: 12/11/2022] Open
Abstract
The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive impairment (MCI), (2) delirium-onset, and (3) psychiatric-onset presentations. The purpose of our review is to determine whether there is sufficient information yet available to justify development of diagnostic criteria for each of these. Our goal is to achieve evidence-based recommendations for the recognition of DLB at a predementia, symptomatic stage. We propose operationalized diagnostic criteria for probable and possible mild cognitive impairment with Lewy bodies, which are intended for use in research settings pending validation for use in clinical practice. They are compatible with current criteria for other prodromal neurodegenerative disorders including Alzheimer and Parkinson disease. Although there is still insufficient evidence to propose formal criteria for delirium-onset and psychiatric-onset presentations of DLB, we feel that it is important to characterize them, raising the index of diagnostic suspicion and prioritizing them for further investigation.
Collapse
Affiliation(s)
- Ian G McKeith
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.).
| | - Tanis J Ferman
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Alan J Thomas
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Frédéric Blanc
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Bradley F Boeve
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Hiroshige Fujishiro
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Kejal Kantarci
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Cristina Muscio
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - John T O'Brien
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Ronald B Postuma
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Dag Aarsland
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Clive Ballard
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Laura Bonanni
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Paul Donaghy
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Murat Emre
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - James E Galvin
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Douglas Galasko
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Jennifer G Goldman
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Stephen N Gomperts
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Lawrence S Honig
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Manabu Ikeda
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - James B Leverenz
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Simon J G Lewis
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Karen S Marder
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Mario Masellis
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - David P Salmon
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - John Paul Taylor
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Debby W Tsuang
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Zuzana Walker
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| | - Pietro Tiraboschi
- From the Newcastle University (I.G.M., A.J.T., P.D., J.P.T.); Mayo Clinic (T.J.F.), Jacksonville; University of Strasbourg (F.B.); Mayo Clinic (B.F.B., K.K.), Rochester; Nagoya University (H.F.), Kawasaki Memorial Hospital; Istituto Neurologico "Carlo Besta" (C.M., P.T.), Milan; Cambridge University (F.M.S.); McGill University (R.B.P.); King's College London and Stavanger University Hospital (D.A.); University of Exeter (C.B.); University of Chieti-Pescara (L.B.); Istanbul Faculty of Medicine (M.E.); University of Miami Miller School of Medicine (J.E.G.); University of California (D.G., D.P.S.), San Diego; Feinberg School of Medicine (J.G.G.); Massachusetts General Hospital (S.N.G.); Columbia University Irving Medical Center (L.S.H., K.S.M.); Osaka University (M.I.); Lou Ruvo Center of Brain Health (J.B.L.), Cleveland Clinic; University of Sydney (S.J.G.L.); Sunnybrook Health Sciences Centre (M.M.), University of Toronto; VA Puget Sound & University of Washington (D.W.T.); University College London (Z.W.)
| |
Collapse
|
17
|
Silvaggi F, Leonardi M, Tiraboschi P, Muscio C, Toppo C, Raggi A. Keeping People with Dementia or Mild Cognitive Impairment in Employment: A Literature Review on Its Determinants. Int J Environ Res Public Health 2020; 17:ijerph17030842. [PMID: 32013095 PMCID: PMC7037722 DOI: 10.3390/ijerph17030842] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Revised: 01/24/2020] [Accepted: 01/27/2020] [Indexed: 12/11/2022]
Abstract
Background: Approximately 10–20% of people with early onset dementias (EOD) or mild cognitive impairment (MCI) are aged under 65 and, due to extended working life and increasing prevalence of dementias, they more and more frequently will be present in the active workforce. This review aimed to synthesize the available information about the ability of people with EOD or MCI to retain their participation in the labor workforce. Methods: We searched SCOPUS and EMBASE for peer-reviewed papers that reported studies assessing work ability in employees with EOD or MCI that were published in the period of January 2010 to August 2019. Results: We selected four publications, in which 1012 participants with EOD or MCI were enrolled (41.2% males). Cognitive difficulties rather than motor dysfunction were found to reduce patients’ ability to work. Two main themes emerged: management of dementia in the workplace and the impact of symptoms on working status. Conclusions: EOD and MCI impact on workforce participation by determining problems in executive functions. Although this review was based on a small sample of studies, it can be shown that support in the workplace may act as a facilitator to enhance workforce participation, and occupational health professionals can help patients with EOD or MCI continue working as much as possible.
Collapse
Affiliation(s)
- Fabiola Silvaggi
- UOC Neurologia, Salute Pubblica e Disabilità, Fondazione Irccs Istituto Neurologico Carlo Besta, 20133 Milan, Italy; (M.L.); (C.T.); (A.R.)
- Correspondence: ; Tel.: +39-02-2394-3105
| | - Matilde Leonardi
- UOC Neurologia, Salute Pubblica e Disabilità, Fondazione Irccs Istituto Neurologico Carlo Besta, 20133 Milan, Italy; (M.L.); (C.T.); (A.R.)
| | - Pietro Tiraboschi
- UOC Neurologia 5 – Neuropatologia, Fondazione Irccs Istituto Neurologico Carlo Besta, 20133 Milan, Italy; (P.T.); (C.M.)
| | - Cristina Muscio
- UOC Neurologia 5 – Neuropatologia, Fondazione Irccs Istituto Neurologico Carlo Besta, 20133 Milan, Italy; (P.T.); (C.M.)
| | - Claudia Toppo
- UOC Neurologia, Salute Pubblica e Disabilità, Fondazione Irccs Istituto Neurologico Carlo Besta, 20133 Milan, Italy; (M.L.); (C.T.); (A.R.)
| | - Alberto Raggi
- UOC Neurologia, Salute Pubblica e Disabilità, Fondazione Irccs Istituto Neurologico Carlo Besta, 20133 Milan, Italy; (M.L.); (C.T.); (A.R.)
| |
Collapse
|
18
|
Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa S, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario G, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Salvini Porro G, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB. Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients. Eur J Neurol 2019; 27:475-483. [PMID: 31692118 DOI: 10.1111/ene.14117] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 11/04/2019] [Indexed: 12/14/2022]
Abstract
BACKGROUND AND PURPOSE Biomarkers support the aetiological diagnosis of neurocognitive disorders in vivo. Incomplete evidence is available to drive clinical decisions; available diagnostic algorithms are generic and not very helpful in clinical practice. The aim was to develop a biomarker-based diagnostic algorithm for mild cognitive impairment patients, leveraging on knowledge from recognized national experts. METHODS With a Delphi procedure, experienced clinicians making variable use of biomarkers in clinical practice and representing five Italian scientific societies (neurology - Società Italiana di Neurologia per le Demenze; neuroradiology - Associazione Italiana di Neuroradiologia; biochemistry - Società Italiana di Biochimica Clinica; psychogeriatrics - Associazione Italiana di Psicogeriatria; nuclear medicine - Associazione Italiana di Medicina Nucleare) defined the theoretical framework, relevant literature, the diagnostic issues to be addressed and the diagnostic algorithm. An N-1 majority defined consensus achievement. RESULTS The panellists chose the 2011 National Institute on Aging and Alzheimer's Association diagnostic criteria as the reference theoretical framework and defined the algorithm in seven Delphi rounds. The algorithm includes baseline clinical and cognitive assessment, blood examination, and magnetic resonance imaging with exclusionary and inclusionary roles; dopamine transporter single-photon emission computed tomography (if no/unclear parkinsonism) or metaiodobenzylguanidine cardiac scintigraphy for suspected dementia with Lewy bodies with clear parkinsonism (round VII, votes (yes-no-abstained): 3-1-1); 18 F-fluorodeoxyglucose positron emission tomography for suspected frontotemporal lobar degeneration and low diagnostic confidence of Alzheimer's disease (round VII, 4-0-1); cerebrospinal fluid for suspected Alzheimer's disease (round IV, 4-1-0); and amyloid positron emission tomography if cerebrospinal fluid was not possible/accepted (round V, 4-1-0) or inconclusive (round VI, 5-0-0). CONCLUSIONS These consensus recommendations can guide clinicians in the biomarker-based aetiological diagnosis of mild cognitive impairment, whilst guidelines cannot be defined with evidence-to-decision procedures due to incomplete evidence.
Collapse
Affiliation(s)
- M Boccardi
- IRCCS Istituto Centro S.Giovanni di Dio-Fatebenefratelli, Brescia, Italy.,University of Geneva, Geneva, Switzerland
| | - V Nicolosi
- IRCCS Istituto Centro S.Giovanni di Dio-Fatebenefratelli, Brescia, Italy
| | - C Festari
- IRCCS Istituto Centro S.Giovanni di Dio-Fatebenefratelli, Brescia, Italy.,University of Brescia, Brescia, Italy
| | - A Bianchetti
- Istituto Clinico S. Anna, Brescia, Italy.,Italian Psychogeriatric Association (AIP), Brescia, Italy
| | - S Cappa
- IRCCS Istituto Centro S.Giovanni di Dio-Fatebenefratelli, Brescia, Italy.,University Institute of Higher Studies, Pavia, Italy.,Italian Society of Neurology for the Study of the Dementias (SINdem), Milan, Italy
| | - D Chiasserini
- University of Perugia, Perugia, Italy.,Italian Society of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine (SIBioC), Rimini, Italy
| | - A Falini
- IRCCS San Raffaele Scientific Institute, Milan, Italy.,Vita-Salute San Raffaele University, Milan, Italy.,Italian Association of Neuroradiology (AINR), Milan, Italy
| | - U P Guerra
- Poliambulanza Foundation, Brescia, Italy.,Italian Association of Nuclear Medicine (AIMN), Bari, Italy
| | - F Nobili
- Italian Association of Nuclear Medicine (AIMN), Bari, Italy.,University of Genoa, Genoa, Italy.,IRCCS Ospedale Policlinico San Martino, Genova, Italy
| | - A Padovani
- Italian Society of Neurology for the Study of the Dementias (SINdem), Milan, Italy.,Brescia University Hospital, Brescia, Italy
| | - G Sancesario
- Italian Society of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine (SIBioC), Rimini, Italy.,IRCCS Santa Lucia Foundation, Neuroimmunology Unit Via Ardeatina 354, Rome, Italy
| | - S Morbelli
- University of Genoa, Genoa, Italy.,IRCCS Ospedale Policlinico San Martino, Genova, Italy
| | - L Parnetti
- Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy
| | | | - C Muscio
- IRCCS 'Carlo Besta', Milan, Italy
| | - D Perani
- IRCCS San Raffaele Scientific Institute, Milan, Italy.,Vita-Salute San Raffaele University, Milan, Italy
| | | | - A Beltramello
- Verona University Hospital, Verona, Italy.,IRCCS 'Sacro Cuore-Don Calabria', Negrar, Verona, Italy
| | | | - M Ciaccio
- Italian Society of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine (SIBioC), Rimini, Italy.,University of Palermo, Palermo, Italy
| | - O Schillaci
- University Tor Vergata, Rome, Italy.,IRCCS-Neuromed, Pozzilli, Italy
| | - M Trabucchi
- Italian Psychogeriatric Association (AIP), Brescia, Italy.,University Tor Vergata, Rome, Italy
| | | | - G B Frisoni
- IRCCS Istituto Centro S.Giovanni di Dio-Fatebenefratelli, Brescia, Italy.,University of Geneva, Geneva, Switzerland
| |
Collapse
|
19
|
Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa SF, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario GM, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Porro GS, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB. P1-238: ITALIAN CONSENSUS RECOMMENDATIONS FOR THE ETIOLOGICAL DIAGNOSIS IN MEMORY CLINICS. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Redolfi A, De Francesco S, Palesi F, Kherif F, Muscio C, Nigri A, Bottini G, Frisoni GB, Tagliavini F, Bruzzone MG, Ryvlin P, Démonet JF, Cappa S, D'Angelo E. P1-333: MEDICAL INFORMATICS PLATFORM (MIP): A VALIDATION STUDY ACROSS CLINICAL ITALIAN COHORTS. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Alberto Redolfi
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Silvia De Francesco
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Fulvia Palesi
- Department of Brain and Behavioral Sciences; University of Pavia; Pavia Italy
| | - Ferath Kherif
- Department of Clinical Neurosciences, Leenaards Memory Centre; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne Switzerland
| | - Cristina Muscio
- Division of Neurology V/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Anna Nigri
- Division of Neurology V/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Gabriella Bottini
- Neuropsychology Center; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - Giovanni B. Frisoni
- Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging; University Hospitals and University of Geneva; Geneva Switzerland
- IRCCS Centro San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Fabrizio Tagliavini
- Division of Neurology V/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Maria Grazia Bruzzone
- Division of Neurology V/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Philippe Ryvlin
- Department of Clinical Neurosciences, Leenaards Memory Centre; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne Switzerland
| | - Jean-François Démonet
- Department of Clinical Neurosciences, Leenaards Memory Centre; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne Switzerland
| | - Stefano Cappa
- IRCCS San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Egidio D'Angelo
- Department of Brain and Behavioral Sciences; University of Pavia; Pavia Italy
| | | |
Collapse
|
21
|
Redolfi A, De Francesco S, Palesi F, Kherif F, Muscio C, Nigri A, Bottini G, Frisoni GB, Tagliavini F, Bruzzone MG, Ryvlin P, Démonet JF, Cappa S, D'Angelo E. IC-P-045: MEDICAL INFORMATICS PLATFORM (MIP): A VALIDATION STUDY ACROSS CLINICAL ITALIAN COHORTS. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Alberto Redolfi
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Silvia De Francesco
- Laboratory of Alzheimer's Neuroimaging and Epidemiology - LANE; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Fulvia Palesi
- Department of Brain and Behavioral Sciences; University of Pavia; Pavia Italy
| | - Ferath Kherif
- Department of Clinical Neurosciences, Leenaards Memory Centre; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne Switzerland
| | - Cristina Muscio
- Division of Neurology/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Anna Nigri
- Division of Neurology/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Gabriella Bottini
- Neuropsychology Center; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - Giovanni B. Frisoni
- IRCCS Centro San Giovanni di Dio Fatebenefratelli; Brescia Italy
- Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging; University Hospitals and University of Geneva; Geneva Switzerland
| | - Fabrizio Tagliavini
- Division of Neurology/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Maria Grazia Bruzzone
- Division of Neurology/Neuropathology; Fondazione IRCCS Istituto Neurologico Carlo Besta; Milan Italy
| | - Philippe Ryvlin
- Department of Clinical Neurosciences, Leenaards Memory Centre; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne Switzerland
| | - Jean-François Démonet
- Department of Clinical Neurosciences, Leenaards Memory Centre; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne Switzerland
| | - Stefano Cappa
- IRCCS San Giovanni di Dio Fatebenefratelli; Brescia Italy
| | - Egidio D'Angelo
- Department of Brain and Behavioral Sciences; University of Pavia; Pavia Italy
| | | |
Collapse
|
22
|
Paghera B, Altomare D, Peli A, Morbelli S, Buschiazzo A, Bauckneht M, Giubbini R, Rodella C, Camoni L, Boccardi M, Festari C, Muscio C, Padovani A, Frisoni GB, Guerra UP. Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability? Q J Nucl Med Mol Imaging 2019; 64:414-421. [PMID: 31089074 DOI: 10.23736/s1824-4785.19.03124-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Three different amyloid tracers labeled with 18-flourine have been introduced into clinical use. The leaflets of tracers indicate different visual criteria for PET reporting. In clinical practice, it is not yet ascertained whether these criteria are equivalent in terms of diagnostic accuracy or if anyone is better than another. We aimed to evaluate the inter and intra-rater variability of visual assessment of 18F-Florbetapir PET/CT images among six independent readers with different clinical experience. METHODS We analyzed 252 PET/CT scans, visually assessed by each reader three times, applying independently the three different reading criteria proposed. Each reader evaluated the regional uptake specifying for each cortical region a numeric value of grading of positivity in order to assign a final score. At the end of each reading a level of confidence was determined by assigning a score from 0 (negative) to 4 (positive). After first reading, those cases in which the evaluations by two experienced readers did not match (discordant cases) were independently reevaluated merging all the three different visual interpretation criteria. RESULTS Good agreement was observed for visual interpretation among the six readers' confidence-level using independently the three visual reading criteria: ICC=0.83 (0.80-0.86) for 18F-florbetapir, ICC=0.84 (0.81-0.87) for 18F-florbetaben, and ICC=0.86 (0.83-0.88) for 18F-flutemetamol reading. A good inter-rater agreement was observed for final-score too: ICC=0.74 (0.70-0.78) for 18F-florbetapir; ICC=0.82 (0.79-0.85) for 18F-florbetaben; ICC=0.84 (0.81-0.87) for 18F-flutemetamol. Intra-rater agreement was good for final-score (from 0.76 to 0.90; P<0.001) and confidence-level (Spearman's rho from 0.89 to 1.00; P<0.001). Disagreement between the two experienced readers was observed in 22 of 252 cases (9%). The agreement converged over a second round of independent reading in 12 of 22 cases (54%), by merging all the criteria. CONCLUSIONS All the criteria proposed are useful to determine the grading of positivity or negativity of amyloid deposition and their merging improves the diagnostic confidence and provides a better agreement.
Collapse
Affiliation(s)
- Barbara Paghera
- Department of Nuclear Medicine, University of Brescia, Brescia, Italy -
| | - Daniele Altomare
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), San Giovanni di Dio Clinical Research Center, Brescia, Italy.,Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Alessia Peli
- Department of Nuclear Medicine, University of Brescia, Brescia, Italy
| | - Silvia Morbelli
- Department of Nuclear Medicine, San Martino University Hospital and IRCCS, Genoa, Italy
| | - Ambra Buschiazzo
- Department of Nuclear Medicine, San Martino University Hospital and IRCCS, Genoa, Italy
| | - Matteo Bauckneht
- Department of Nuclear Medicine, San Martino University Hospital and IRCCS, Genoa, Italy
| | - Raffaele Giubbini
- Department of Nuclear Medicine, University of Brescia, Brescia, Italy
| | - Carlo Rodella
- Department of Nuclear Medicine, University of Brescia, Brescia, Italy
| | - Luca Camoni
- Department of Nuclear Medicine, University of Brescia, Brescia, Italy
| | - Marina Boccardi
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), San Giovanni di Dio Clinical Research Center, Brescia, Italy.,Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland
| | - Cristina Festari
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), San Giovanni di Dio Clinical Research Center, Brescia, Italy.,Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Cristina Muscio
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), San Giovanni di Dio Clinical Research Center, Brescia, Italy.,Division of Neurology V - Neuropathology, Carlo Besta Institute of Neurology Foundation and IRCCS, Milan, Italy
| | - Alessandro Padovani
- Unit of Neurology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Giovanni B Frisoni
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), San Giovanni di Dio Clinical Research Center, Brescia, Italy.,Department of Nuclear Medicine, San Martino University Hospital and IRCCS, Genoa, Italy.,Memory Clinic, University Hospital of Geneva, Geneva, Switzerland
| | - Ugo P Guerra
- Department of Nuclear Medicine, Poliambulanza Foundation, Brescia, Italy
| |
Collapse
|
23
|
Chiappiniello A, Tarducci R, Muscio C, Frisoni G, Bruzzone M, Bozzali M, Perani D, Tiraboschi P, Nigri A, Ambrosi C, Caulo M, Chipi E, Chiti S, Fainardi E, Ferraro S, Festari C, Gasparotti R, Ginestroni A, Giulietti G, Mascaro L, Navarra R, Nicolosi V, Parnetti L, Rosazza C, Serra L, Tagliavini F, Jovicich J. 22. Multicentric test-retest reproducibility of human hippocampal volumes with FreeSurfer 6.0: A comparison between standard and longitudinal hippocampal subfields segmentation streams applied to 3D T1, 3D FLAIR and high-resolution 2D T2 neuroimaging. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
24
|
Presotto L, Iaccarino L, Sala A, Vanoli EG, Muscio C, Nigri A, Bruzzone MG, Tagliavini F, Gianolli L, Perani D, Bettinardi V. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification. Neuroimage Clin 2018; 20:153-160. [PMID: 30094164 PMCID: PMC6072675 DOI: 10.1016/j.nicl.2018.07.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2018] [Revised: 06/22/2018] [Accepted: 07/13/2018] [Indexed: 12/17/2022]
Abstract
The reference standard for spatial normalization of brain positron emission tomography (PET) images involves structural Magnetic Resonance Imaging (MRI) data. However, the lack of such structural information is fairly common in clinical settings. This might lead to lack of proper image quantification and to evaluation based only on visual ratings, which does not allow research studies or clinical trials based on quantification. PET/CT systems are widely available and CT normalization procedures need to be explored. Here we describe and validate a procedure for the spatial normalization of PET images based on the low-dose Computed Tomography (CT) images contextually acquired for attenuation correction in PET/CT systems. We included N = 34 subjects, spanning from cognitively normal to mild cognitive impairment and dementia, who underwent amyloid-PET/CT (18F-Florbetaben) and structural MRI scans. The proposed pipeline is based on the SPM12 unified segmentation algorithm applied to low-dose CT images. The validation of the normalization pipeline focused on 1) statistical comparisons between regional and global 18F-Florbetaben-PET/CT standardized uptake value ratios (SUVrs) estimated from both CT-based and MRI-based normalized PET images (SUVrCT, SUVrMRI) and 2) estimation of the degrees of overlap between warped gray matter (GM) segmented maps derived from CT- and MRI-based spatial transformations. We found negligible deviations between regional and global SUVrs in the two CT and MRI-based methods. SUVrCT and SUVrMRI global uptake scores showed negligible differences (mean ± sd 0.01 ± 0.03). Notably, the CT- and MRI-based warped GM maps showed excellent overlap (90% within 1 mm). The proposed analysis pipeline, based on low-dose CT images, allows accurate spatial normalization and subsequent PET image quantification. A CT-based analytical pipeline could benefit both research and clinical practice, allowing the recruitment of larger samples and favoring clinical routine analysis.
Collapse
Affiliation(s)
- Luca Presotto
- Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy
| | - Leonardo Iaccarino
- Vita-Salute San Raffaele University, Milan, Italy; In vivo human molecular and structural neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Arianna Sala
- Vita-Salute San Raffaele University, Milan, Italy; In vivo human molecular and structural neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Emilia G Vanoli
- Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy
| | - Cristina Muscio
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milano, Italy
| | - Anna Nigri
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milano, Italy
| | - Maria Grazia Bruzzone
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milano, Italy
| | - Fabrizio Tagliavini
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milano, Italy
| | - Luigi Gianolli
- Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy
| | - Daniela Perani
- Nuclear Medicine Unit, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy; In vivo human molecular and structural neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
| | | |
Collapse
|
25
|
Altomare D, Ferrari C, Festari C, Guerra UP, Muscio C, Padovani A, Frisoni GB, Boccardi M. Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET. Alzheimers Dement 2018; 14:1088-1098. [PMID: 29679576 DOI: 10.1016/j.jalz.2018.02.022] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Revised: 01/27/2018] [Accepted: 02/22/2018] [Indexed: 02/04/2023]
Abstract
INTRODUCTION We test the hypothesis that amyloid-positron emission tomography prescriptions, considered appropriate based on the Amyloid Imaging Taskforce (AIT) criteria, lead to greater clinical utility than AIT-inappropriate prescriptions. METHODS We compared the clinical utility between patients who underwent amyloid-positron emission tomography appropriately or inappropriately and among the subgroups of patients defined by the AIT criteria. Finally, we performed logistic regressions to identify variables associated with clinical utility. RESULTS We identified 171 AIT-appropriate and 67 AIT-inappropriate patients. AIT-appropriate and AIT-inappropriate cases did not differ in any outcomes of clinical utility (P > .05). Subgroup analysis denoted both expected and unexpected results. The logistic regressions outlined the primary role of clinical picture and clinical or neuropsychological profile in identifying patients benefitting from amyloid-positron emission tomography. DISCUSSION Contrary to our hypothesis, also AIT-inappropriate prescriptions were associated with clinical utility. Clinical or neuropsychological variables, not taken into account by the AIT criteria, may help further refine criteria for appropriateness.
Collapse
Affiliation(s)
- Daniele Altomare
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Clarissa Ferrari
- Unit of Statistics, Saint John of God Clinical Research Centre, Brescia, Italy
| | - Cristina Festari
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Ugo Paolo Guerra
- Department of Nuclear Medicine, Poliambulanza Foundation, Brescia, Italy
| | - Cristina Muscio
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy; Division of Neurology V-Neuropathology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan, Italy
| | - Alessandro Padovani
- Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy
| | - Giovanni B Frisoni
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy; Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland; Memory Clinic, University Hospital of Geneva, Geneva, Switzerland
| | - Marina Boccardi
- Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy; Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
| |
Collapse
|
26
|
Muscio C, Tiraboschi P. What is the best imaging technique in discriminating dementia with Lewy bodies from other dementias? Geriatr Gerontol Int 2017; 17:857. [DOI: 10.1111/ggi.12950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Accepted: 09/26/2016] [Indexed: 11/29/2022]
Affiliation(s)
- Cristina Muscio
- Division of Neurology V/Neuropathology; Fondazione IRCCS Istituto Neurologico “Carlo Besta”; Milan Italy
| | - Pietro Tiraboschi
- Division of Neurology V/Neuropathology; Fondazione IRCCS Istituto Neurologico “Carlo Besta”; Milan Italy
| |
Collapse
|
27
|
Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, Pizzocaro C, Lussignoli G, Geroldi C, Zanetti O, Cotelli MS, Turla M, Borroni B, Rozzini L, Mirabile D, Defanti C, Gennuso M, Prelle A, Gentile S, Morandi A, Vollaro S, Volta GD, Bianchetti A, Conti MZ, Cappuccio M, Carbone P, Bellandi D, Abruzzi L, Bettoni L, Villani D, Raimondi MC, Lanari A, Ciccone A, Facchi E, Di Fazio I, Rozzini R, Boffelli S, Manzoni L, Salvi GP, Cavaliere S, Belotti G, Avanzi S, Pasqualetti P, Muscio C, Padovani A, Frisoni GB. Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment. JAMA Neurol 2016; 73:1417-1424. [DOI: 10.1001/jamaneurol.2016.3751] [Citation(s) in RCA: 72] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Affiliation(s)
- Marina Boccardi
- LANVIE–Laboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland2Laboratory of Alzheimer’s Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Daniele Altomare
- Laboratory of Alzheimer’s Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy3Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Clarissa Ferrari
- Unit of Statistics, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Cristina Festari
- Laboratory of Alzheimer’s Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy3Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Ugo Paolo Guerra
- Department of Nuclear Medicine, Poliambulanza Foundation, Brescia, Italy
| | - Barbara Paghera
- Department of Nuclear Medicine, University of Brescia, Brescia, Italy
| | - Claudio Pizzocaro
- Department of Nuclear Medicine, Poliambulanza Foundation, Brescia, Italy
| | - Giulia Lussignoli
- Alzheimer’s Unit, Memory Clinic, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Cristina Geroldi
- Alzheimer’s Unit, Memory Clinic, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Orazio Zanetti
- Alzheimer’s Unit, Memory Clinic, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | | | - Marinella Turla
- Neurology Unit, Ospedale di Vallecamonica Esine, Brescia, Italy
| | - Barbara Borroni
- Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy
| | - Luca Rozzini
- Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy
| | - Dario Mirabile
- European Foundation Biomedical Research, Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy
| | - Carlo Defanti
- European Foundation Biomedical Research, Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy
| | | | | | - Simona Gentile
- Department of Rehabilitation, Fondazione Teresa Camplani, Casa di cura Ancelle della Carità, Cremona, Italy
| | - Alessandro Morandi
- Department of Rehabilitation, Fondazione Teresa Camplani, Casa di cura Ancelle della Carità, Cremona, Italy
| | - Stefano Vollaro
- Neurology Unit, Istituto Clinico Città di Brescia, Brescia, Italy
| | | | - Angelo Bianchetti
- Department of Medicine and Rehabilitation, Istituto Clinico Sant’Anna, Brescia, Italy
| | - Marta Zaffira Conti
- Hospice, Istituto Polifunzionale Sociosanitario Foundation Cardinal Giorgio Gusmini, Vertova, Bergamo, Italy
| | - Melania Cappuccio
- Hospice, Istituto Polifunzionale Sociosanitario Foundation Cardinal Giorgio Gusmini, Vertova, Bergamo, Italy
| | - Pasqualina Carbone
- Alzheimer Evaluation Unit, Istituto Ospedaliero di Sospiro Non-Profit Organization of Social Utility Foundation, Sospiro, Cremona, Italy
| | - Daniele Bellandi
- Alzheimer Evaluation Unit, Istituto Ospedaliero di Sospiro Non-Profit Organization of Social Utility Foundation, Sospiro, Cremona, Italy
| | - Luciano Abruzzi
- Neurology Unit, Istituti Ospedalieri di Cremona, Cremona, Italy
| | - Luigi Bettoni
- Neurology Unit, Istituti Ospedalieri di Cremona, Cremona, Italy
| | - Daniele Villani
- Alzheimer Evaluation Unit, Casa di Cura Figlie di S. Camillo, Cremona, Italy
| | | | | | | | - Emanuela Facchi
- Geriatric General Rehabilitation, Fondazione Richiedei, Palazzolo sull'Oglio, Brescia, Italy
| | - Ignazio Di Fazio
- Geriatric General Rehabilitation, Fondazione Richiedei, Palazzolo sull'Oglio, Brescia, Italy
| | - Renzo Rozzini
- Neurology Unit, Poliambulanza Foundation, Brescia, Italy
| | | | - Laura Manzoni
- Neuromotor and Cognitive Rehabilitation Center, Clinic Quarenghi, San Pellegrino Terme, Bergamo, Italy
| | - Giovanni Pietro Salvi
- Neuromotor and Cognitive Rehabilitation Center, Clinic Quarenghi, San Pellegrino Terme, Bergamo, Italy
| | - Sabina Cavaliere
- Alzheimer Evaluation Unit, Hospice Santa Maria Ausiliatrice Onlus Foundation, Bergamo, Italy
| | - Gloria Belotti
- Alzheimer Evaluation Unit, Hospice Santa Maria Ausiliatrice Onlus Foundation, Bergamo, Italy
| | - Stefano Avanzi
- Neuromotor Rehabilitation Medicine, Salvatore Maugeri Foundation Clinic of Work and Rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico, Castel Goffredo, Mantova, Italy
| | - Patrizio Pasqualetti
- Service of Medical Statistics and Information Technology, Fatebenefratelli Foundation for Health Research and Education, Rome, Italy
| | - Cristina Muscio
- Laboratory of Alzheimer’s Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy26Division of Neurology V–Neuropathology, Fondazione, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan, Italy
| | - Alessandro Padovani
- Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy
| | - Giovanni B. Frisoni
- LANVIE–Laboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland2Laboratory of Alzheimer’s Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy27Memory Clinic, University Hospital of Geneva, Geneva, Switzerland
| | | |
Collapse
|
28
|
Bonanni L, Cagnin A, Agosta F, Babiloni C, Borroni B, Bozzali M, Bruni AC, Filippi M, Galimberti D, Monastero R, Muscio C, Parnetti L, Perani D, Serra L, Silani V, Tiraboschi P, Padovani A. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design. Neurol Sci 2016; 38:83-91. [DOI: 10.1007/s10072-016-2713-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2016] [Accepted: 09/08/2016] [Indexed: 01/23/2023]
|
29
|
Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 2016; 49:60-68. [PMID: 27776263 DOI: 10.1016/j.neurobiolaging.2016.08.019] [Citation(s) in RCA: 755] [Impact Index Per Article: 94.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2015] [Revised: 08/23/2016] [Accepted: 08/24/2016] [Indexed: 12/14/2022]
Abstract
The pathway leading from amyloid-β deposition to cognitive impairment is believed to be a cornerstone of the pathogenesis of Alzheimer's disease (AD). However, what drives amyloid buildup in sporadic nongenetic cases of AD is still unknown. AD brains feature an inflammatory reaction around amyloid plaques, and a specific subset of the gut microbiota (GMB) may promote brain inflammation. We investigated the possible role of the GMB in AD pathogenesis by studying the association of brain amyloidosis with (1) GMB taxa with pro- and anti-inflammatory activity; and (2) peripheral inflammation in cognitively impaired patients. We measured the stool abundance of selected bacterial GMB taxa (Escherichia/Shigella, Pseudomonas aeruginosa, Eubacterium rectale, Eubacterium hallii, Faecalibacterium prausnitzii, and Bacteroides fragilis) and the blood expression levels of cytokines (pro-inflammatory cytokines: CXCL2, CXCL10, interleukin [IL]-1β, IL-6, IL-18, IL-8, inflammasome complex (NLRP3), tumor necrosis factor-alpha [TNF-α]; anti-inflammatory cytokines: IL-4, IL-10, IL-13) in cognitively impaired patients with (n = 40, Amy+) and with no brain amyloidosis (n = 33, Amy-) and also in a group of controls (n = 10, no brain amyloidosis and no cognitive impairment). Amy+ patients showed higher levels of pro-inflammatory cytokines (IL-6, CXCL2, NLRP3, and IL-1β) compared with both controls and with Amy- patients. A reduction of the anti-inflammatory cytokine IL-10 was observed in Amy+ versus Amy-. Amy+ showed lower abundance of E. rectale and higher abundance of Escherichia/Shigella compared with both healthy controls (fold change, FC = -9.6, p < 0.001 and FC = +12.8, p < 0.001, respectively) and to Amy- (FC = -7.7, p < 0.001 and FC = +7.4, p = 0.003). A positive correlation was observed between pro-inflammatory cytokines IL-1β, NLRP3, and CXCL2 with abundance of the inflammatory bacteria taxon Escherichia/Shigella (rho = 0.60, p < 0.001; rho = 0.57, p < 0.001; and rho = 0.30, p = 0.007, respectively) and a negative correlation with the anti-inflammatory E. rectale (rho = -0.48, p < 0.001; rho = -0.25, p = 0.024; rho = -0.49, p < 0.001). Our data indicate that an increase in the abundance of a pro-inflammatory GMB taxon, Escherichia/Shigella, and a reduction in the abundance of an anti-inflammatory taxon, E. rectale, are possibly associated with a peripheral inflammatory state in patients with cognitive impairment and brain amyloidosis. A possible causal relation between GMB-related inflammation and amyloidosis deserves further investigation.
Collapse
Affiliation(s)
- Annamaria Cattaneo
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy; King's College London, Institute of Psychiatry, London, UK.
| | - Nadia Cattane
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy
| | - Samantha Galluzzi
- Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Stefania Provasi
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy
| | - Nicola Lopizzo
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy
| | - Cristina Festari
- Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Clarissa Ferrari
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy
| | - Ugo Paolo Guerra
- Nuclear Medicine, Poliambulanza Foundation, Istituto Ospedaliero, Brescia, Italy
| | - Barbara Paghera
- Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy
| | - Cristina Muscio
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy; European Foundation Biomedical Research (FERB), Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy
| | - Angelo Bianchetti
- Department of Medicine and Rehabilitation, Istituto Clinico Sant'Anna, Brescia, Italy
| | | | - Marinella Turla
- Neurology Unit, Ospedale di Vallecamonica Esine, Brescia, Italy
| | | | | | | | - Orazio Zanetti
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy
| | - Giulia Lussignoli
- Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy
| | - Dario Mirabile
- European Foundation Biomedical Research (FERB), Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy
| | - Daniele Bellandi
- Alzheimer Evaluation Unit, Istituto Ospedaliero di Sospiro ONLUS Foundation, Cremona, Italy
| | - Simona Gentile
- Department of Rehabilitation, Casa di Cura Ancelle della Carità, Cremona, Italy
| | - Gloria Belotti
- Alzheimer Evaluation Unit, Hospice Santa Maria Ausiliatrice ONLUS Foundation, Bergamo, Italy
| | - Daniele Villani
- Alzheimer Evaluation Unit, Casa di Cura Figlie di S. Camillo, Cremona, Italy
| | - Taoufiq Harach
- Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland
| | | | - Alessandro Padovani
- Neurology Unit, Department of Medical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Marina Boccardi
- Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - Giovanni B Frisoni
- Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals, Geneva, Switzerland; Memory Clinic, University Hospitals and University of Geneva, Geneva, Switzerland
| |
Collapse
|
30
|
Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C. 123
I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐
N
‐(3‐fluoropropyl) nortropane single photon emission computed tomography and
123
I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study. Ann Neurol 2016; 80:368-78. [DOI: 10.1002/ana.24717] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2016] [Revised: 06/27/2016] [Accepted: 06/28/2016] [Indexed: 01/09/2023]
Affiliation(s)
- Pietro Tiraboschi
- Division of Neurology V/Neuropathology, Scientific Institute for Research, Hospitalization, and Care (IRCCS), Foundation “Carlo Besta” Neurological InstituteMilan Italy
| | - Angelo Corso
- Department of Nuclear MedicineSant'Anna HospitalComo Italy
| | - Ugo Paolo Guerra
- Department of Nuclear MedicinePoliambulanza FoundationBrescia Italy
| | - Flavio Nobili
- Department of NeuroscienceUniversity of GenoaGenoa Italy
| | - Arnoldo Piccardo
- Nuclear Medicine Unit, Department of Diagnostic ImagingE. O. Galliera HospitalGenoa Italy
| | | | | | - Diego Cecchin
- Department of MedicineUniversity of PaduaPadua Italy
| | - Mauro Tettamanti
- Laboratory of Geriatric Neuropsychiatry, Institute of Hospitalization and Scientific Care Mario Negri Institute of Pharmacological ResearchMilan Italy
| | - Luigi Antelmi
- Health Department, Institute of Hospitalization and Scientific Care Foundation Carlo Besta Neurological InstituteMilan Italy
| | - Simone Vidale
- Department of Neurology and Stroke UnitSant'Anna HospitalComo Italy
| | - Leonardo Sacco
- Department of Neurology and Stroke UnitSant'Anna HospitalComo Italy
- Neurocenter of Southern SwitzerlandLugano Switzerland
| | - Maria Merello
- European Foundation for Biomedical Research, Alzheimer Center of Excellence, Briolini Hospital of GazzanigaBergamo Italy
| | - Stefano Stefanini
- European Foundation for Biomedical Research, Alzheimer Center of Excellence, Briolini Hospital of GazzanigaBergamo Italy
| | - Anna Micheli
- Neurology Unit, San Francesco ClinicBergamo Italy
| | - Paola Vai
- Department of Nuclear MedicinePapa Giovanni XXIII HospitalBergamo Italy
| | - Selene Capitanio
- Department of Nuclear MedicinePapa Giovanni XXIII HospitalBergamo Italy
| | | | - Riccardo Riva
- Department of NeurologyPapa Giovanni XXIII HospitalBergamo Italy
| | - Patrizia Pinto
- Department of NeurologyPapa Giovanni XXIII HospitalBergamo Italy
| | - Ave Maria Biffi
- Department of PsychologyPapa Giovanni XXIII HospitalBergamo Italy
| | - Cristina Muscio
- Division of Neurology V/Neuropathology, Scientific Institute for Research, Hospitalization, and Care (IRCCS), Foundation “Carlo Besta” Neurological InstituteMilan Italy
| | | |
Collapse
|
31
|
Altomare D, Festari C, Ferrari C, Muscio C, Padovani A, Frisoni GB, Boccardi M. IC‐P‐007: Brain Amyloidosis and Cognitive Decline in MCI: 12‐Month Follow‐Up. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Daniele Altomare
- IRCCS FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
| | - Cristina Festari
- IRCCS FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
| | | | - Cristina Muscio
- IRCCS FatebenefratelliBresciaItaly
- Fondazione IRCCS Istituto NeurologicoMilanoItaly
| | | | | | | | | |
Collapse
|
32
|
Altomare D, Ferrari C, Festari C, Muscio C, Zanetti O, Turla M, Defanti C, Prelle A, Gentile S, Volta GD, Padovani A, Frisoni GB, Boccardi M. IC‐P‐005: Does Clinical Use of Amyloid‐Pet Affect Physicians’ Beliefs on The Pathogenetic Role of Amyloid‐β and The Clinical Usage of Amyloid‐Pet? Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Daniele Altomare
- IRCCS FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
| | | | - Cristina Festari
- IRCCS FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
| | - Cristina Muscio
- IRCCS FatebenefratelliBresciaItaly
- Fondazione IRCCS Istituto NeurologicoMilanoItaly
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Altomare D, Festari C, Muscio C, Padovani A, Frisoni GB, Boccardi M. P3‐302: Brain Amyloidosis and Cognitive Decline in MCI: 12‐Month Follow‐Up. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.1966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Daniele Altomare
- IRCCS FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
| | - Cristina Festari
- IRCCS FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
| | - Cristina Muscio
- IRCCS FatebenefratelliBresciaItaly
- Fondazione IRCCS Istituto NeurologicoMilanoItaly
| | | | | | | | | |
Collapse
|
34
|
Festari C, Altomare D, Bocchetta M, Muscio C, Padovani A, Frisoni GB, Boccardi M, Boccardi M. O2‐08‐04: Is the Incremental Diagnostic Value of Amyloid‐Pet Affected by Information on Other Core Biomarkers? Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Cristina Festari
- IRCCS Fatebenefratelli BresciaItaly
- University of BresciaBresciaItaly
| | - Daniele Altomare
- IRCCS Fatebenefratelli BresciaItaly
- University of BresciaBresciaItaly
| | - Martina Bocchetta
- IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliBresciaItaly
| | - Cristina Muscio
- IRCCS Fatebenefratelli BresciaItaly
- Fondazione IRCCS Istituto Neurologico MilanoItaly
| | | | - Giovanni B. Frisoni
- IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliBresciaItaly
- University of GenevaGenevaSwitzerland
- Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of GenevaGenevaSwitzerland
| | | | | | | |
Collapse
|
35
|
Boccardi M, Altomare D, Ferrari C, Festari C, Antelmi L, Tarallo A, Pasqualetti P, Muscio C, Guerra U, Paghera B, Padovani A, Frisoni G. The incremental diagnostic value of 18F-Florbetapir imaging in naturalistic patients with cognitive impairment: final results from the india-FBP study. Neurobiol Aging 2016. [DOI: 10.1016/j.neurobiolaging.2016.01.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Boccardi M, Altomare D, Ferrari C, Festari C, Antelmi L, Pievani M, Tarallo A, Muscio C, Guerra UP, Paghera B, Padovani A, Frisoni GB. Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic? NEURODEGENER DIS 2015; 16:111-7. [DOI: 10.1159/000439255] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2015] [Accepted: 08/07/2015] [Indexed: 11/19/2022] Open
|
37
|
Boccardi M, Altomare D, Guerra UP, Pievani M, Albanese E, Festari C, Pasqualetti P, Muscio C, Nobili F, Padovani A, Frisoni GB. P4‐250: Appraisal of the utility of the amyloid imaging taskforce recommendations for amyloid‐PET prescription. Alzheimers Dement 2015. [DOI: 10.1016/j.jalz.2015.08.079] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
| | | | | | | | | | | | | | - Cristina Muscio
- IRCCS Saint John of God FatebenefratelliBresciaItaly
- Ospedale Briolini of GazzanigaBergamoItaly
| | | | | | - Giovanni Battista Frisoni
- IRCCS Saint John of God FatebenefratelliBresciaItaly
- University of GenevaGenevaSwitzerland
- University HospitalsGenevaSwitzerland
| | | |
Collapse
|
38
|
Boccardi M, Altomare D, Festari C, Tarallo A, Guerra UP, Paghera B, Pizzocaro C, Muscio C, Pievani M, Padovani A, Frisoni GB. P2‐158: The incremental diagnostic value of 18F‐florbetapir imaging in naturalistic patients with cognitive impairment: The India‐FBP study. Alzheimers Dement 2015. [DOI: 10.1016/j.jalz.2015.06.697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Marina Boccardi
- IRCCS Centro San Giovanni di Dio FatebenefratelliBresciaItaly
| | | | | | - Anna Tarallo
- IRCCS Centro San Giovanni di Dio FatebenefratelliBresciaItaly
| | | | - Barbara Paghera
- University of BresciaBresciaItaly
- Spedali Civili di BresciaBresciaItaly
| | | | - Cristina Muscio
- IRCCS Centro San Giovanni di Dio FatebenefratelliBresciaItaly
- Ospedale Briolini of GazzanigaBergamoItaly
| | - Michela Pievani
- IRCCS Centro San Giovanni di Dio FatebenefratelliBresciaItaly
| | | | - Giovanni Battista Frisoni
- IRCCS Centro San Giovanni di Dio FatebenefratelliBresciaItaly
- University of BresciaBresciaItaly
- University Hospitals and University of GenevaGenevaSwitzerland
| | | |
Collapse
|
39
|
Muscio C, Tiraboschi P, Guerra UP, Defanti CA, Frisoni GB. Clinical trial design of serious gaming in mild cognitive impairment. Front Aging Neurosci 2015; 7:26. [PMID: 25814951 PMCID: PMC4356084 DOI: 10.3389/fnagi.2015.00026] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2015] [Accepted: 02/23/2015] [Indexed: 11/29/2022] Open
Affiliation(s)
- Cristina Muscio
- Fondazione Europea Ricerca Biomedica, Centro Eccellenza Alzheimer Ospedale Briolini, Bergamo, Italy ; Department of Molecular and Translational Medicine, University of Brescia Brescia, Italy
| | - Pietro Tiraboschi
- Division of Neurology V/Neuropathology, Fondazione IRCCS Istituto Neurologico "Carlo Besta" Milan, Italy
| | - Ugo P Guerra
- Fondazione Poliambulanza, Nuclear Medicine Department Brescia, Italy
| | - Carlo A Defanti
- Fondazione Europea Ricerca Biomedica, Centro Eccellenza Alzheimer Ospedale Briolini, Bergamo, Italy
| | - Giovanni B Frisoni
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio-Fatebenefratelli Brescia, Italy ; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva Geneva, Switzerland
| |
Collapse
|
40
|
Vos SJB, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BNM, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S, Freund-Levi Y, Wallin ÅK, Hampel H, van der Flier W, Scheltens P, Visser PJ. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain 2015; 138:1327-38. [PMID: 25693589 DOI: 10.1093/brain/awv029] [Citation(s) in RCA: 228] [Impact Index Per Article: 25.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Accepted: 12/15/2014] [Indexed: 12/16/2022] Open
Abstract
Three sets of research criteria are available for diagnosis of Alzheimer's disease in subjects with mild cognitive impairment: the International Working Group-1, International Working Group-2, and National Institute of Aging-Alzheimer Association criteria. We compared the prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage according to these criteria. Subjects with mild cognitive impairment (n = 1607), 766 of whom had both amyloid and neuronal injury markers, were recruited from 13 cohorts. We used cognitive test performance and available biomarkers to classify subjects as prodromal Alzheimer's disease according to International Working Group-1 and International Working Group-2 criteria and in the high Alzheimer's disease likelihood group, conflicting biomarker groups (isolated amyloid pathology or suspected non-Alzheimer pathophysiology), and low Alzheimer's disease likelihood group according to the National Institute of Ageing-Alzheimer Association criteria. Outcome measures were the proportion of subjects with Alzheimer's disease at the mild cognitive impairment stage and progression to Alzheimer's disease-type dementia. We performed survival analyses using Cox proportional hazards models. According to the International Working Group-1 criteria, 850 (53%) subjects had prodromal Alzheimer's disease. Their 3-year progression rate to Alzheimer's disease-type dementia was 50% compared to 21% for subjects without prodromal Alzheimer's disease. According to the International Working Group-2 criteria, 308 (40%) subjects had prodromal Alzheimer's disease. Their 3-year progression rate to Alzheimer's disease-type dementia was 61% compared to 22% for subjects without prodromal Alzheimer's disease. According to the National Institute of Ageing-Alzheimer Association criteria, 353 (46%) subjects were in the high Alzheimer's disease likelihood group, 49 (6%) in the isolated amyloid pathology group, 220 (29%) in the suspected non-Alzheimer pathophysiology group, and 144 (19%) in the low Alzheimer's disease likelihood group. The 3-year progression rate to Alzheimer's disease-type dementia was 59% in the high Alzheimer's disease likelihood group, 22% in the isolated amyloid pathology group, 24% in the suspected non-Alzheimer pathophysiology group, and 5% in the low Alzheimer's disease likelihood group. Our findings support the use of the proposed research criteria to identify Alzheimer's disease at the mild cognitive impairment stage. In clinical settings, the use of both amyloid and neuronal injury markers as proposed by the National Institute of Ageing-Alzheimer Association criteria offers the most accurate prognosis. For clinical trials, selection of subjects in the National Institute of Ageing-Alzheimer Association high Alzheimer's disease likelihood group or the International Working Group-2 prodromal Alzheimer's disease group could be considered.
Collapse
Affiliation(s)
- Stephanie J B Vos
- 1 Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht, The Netherlands
| | - Frans Verhey
- 1 Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht, The Netherlands
| | - Lutz Frölich
- 2 Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany
| | - Johannes Kornhuber
- 3 Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen, Erlangen, Germany
| | - Jens Wiltfang
- 4 Department of Psychiatry and Psychotherapy, University Medical Centre (UMG), Georg-August-University, Göttingen, Germany
| | - Wolfgang Maier
- 5 Department of Psychiatry and Psychotherapy, University of Bonn, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany
| | - Oliver Peters
- 6 Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany
| | - Eckart Rüther
- 7 Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany
| | - Flavio Nobili
- 8 Clinical Neurophysiology Service, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
| | - Silvia Morbelli
- 9 Nuclear Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy
| | - Giovanni B Frisoni
- 10 IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy 11 University Hospitals and University of Geneva, Geneva, Switzerland
| | - Alexander Drzezga
- 12 Department of Nuclear Medicine, University of Cologne, Cologne, Germany
| | - Mira Didic
- 13 Service de Neurologie et Neuropsychologie, Pôle de neurosciences cliniques, AP-HM Timone, Aix Marseille Université, INS UMR_S 1106, 13005, Marseille, France
| | - Bart N M van Berckel
- 14 Department of Nuclear Medicine and PET Research, VU University Medical CentRE, Amsterdam, The Netherlands
| | - Andrew Simmons
- 15 Department of Neuroimaging, Centre for Neuroimaging Science, King's College London, Institute of Psychiatry, London, UK
| | - Hilkka Soininen
- 16 Institute of Clinical Medicine, Neurology, University of Eastern Finland and Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland
| | | | - Patrizia Mecocci
- 18 Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy
| | - Magda Tsolaki
- 19 Aristotle University of Thessaloniki, Memory and Dementia Center, 3rd Department of Neurology, "G Papanicolaou" General Hospital, Thessaloniki, Greece
| | - Bruno Vellas
- 20 UMR INSERM 1027, CHU Toulouse, Toulouse, France
| | - Simon Lovestone
- 21 University of Oxford, Department of Psychiatry, Oxford, UK
| | - Cristina Muscio
- 10 IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy 22 Fondazione Europea Ricerca Biomedica (FERB), Centro di Eccellenza Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy 23 Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Sanna-Kaisa Herukka
- 16 Institute of Clinical Medicine, Neurology, University of Eastern Finland and Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland
| | - Eric Salmon
- 24 Memory Clinic, Department of Neurology, CHU Liège, Belgium 25 Cyclotron Research Centre, University of Liège, Liège, Belgium
| | - Christine Bastin
- 25 Cyclotron Research Centre, University of Liège, Liège, Belgium
| | - Anders Wallin
- 26 Department of Psychiatry and Neurochemistry, Institute for Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Arto Nordlund
- 26 Department of Psychiatry and Neurochemistry, Institute for Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Alexandre de Mendonça
- 27 Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Portugal
| | - Dina Silva
- 27 Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Portugal
| | - Isabel Santana
- 28 Department of Neurology, Coimbra University Hospital, Coimbra, Portugal
| | - Raquel Lemos
- 29 Faculty of Psychology and Educational Sciences, University of Coimbra, Coimbra, Portugal
| | - Sebastiaan Engelborghs
- 30 Reference Centre for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium 31 Department of Neurology and Memory Clinic, Hospital Network Antwerp, Middelheim and Hoge Beuken, Antwerp, Belgium
| | - Stefan Van der Mussele
- 30 Reference Centre for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
| | | | - Yvonne Freund-Levi
- 32 Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, and Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
| | - Åsa K Wallin
- 33 Lund University, Clinical Sciences Malmö, Clinical Memory Research Unit, Lund, Sweden
| | - Harald Hampel
- 34 Centre des Maladies Cognitives et Comportementales, Institut du Cerveau et de la Moelle épinière, Paris, France; Université Pierre et Marie Curie-Paris 6, AP-HP, Hôpital de la Salpêtrière, Paris, France
| | - Wiesje van der Flier
- 35 Alzheimer Centre and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
| | - Philip Scheltens
- 35 Alzheimer Centre and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
| | - Pieter Jelle Visser
- 1 Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht, The Netherlands 35 Alzheimer Centre and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
| |
Collapse
|
41
|
Preti A, Muscio C, Boccardi M, Lorenzi M, de Girolamo G, Frisoni G. Impact of alcohol consumption in healthy adults: a magnetic resonance imaging investigation. Psychiatry Res 2014; 224:96-103. [PMID: 25172407 DOI: 10.1016/j.pscychresns.2014.06.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2013] [Revised: 02/17/2014] [Accepted: 06/22/2014] [Indexed: 02/05/2023]
Abstract
The impact of alcohol on brain morphology was studied in a large group of cognitively intact people whose consumption of alcohol was below the threshold for abuse. Participants were 367 healthy subjects, aged 18 years or older, who underwent magnetic resonance imaging (MRI) for reasons other than cognitive impairment. MRI analyses were carried out using SPM8 software on the MATLAB 7.9 platform. Gray matter (GM) and white matter (WM) volumes were normalized for intracranial volume. Participants were interviewed about their lifetime consumption of alcohol, nicotine and other available illicit substances. Direct WM and GM comparisons between alcohol users and non-users did not detect significant differences. Differences also did not emerge from multiple regression analyses or in the subgroup aged 65 or older. Based on this study's findings, we cannot infer a detrimental effect of alcohol on the brain of normal adults. These data may be considered to provide reference information for clinical studies.
Collapse
Affiliation(s)
- Antonio Preti
- Genneruxi Medical Center, Cagliari, Italy; IRCCS Centro San Giovanni di Dio-Fatebenefratelli, via Pilastroni 4, 20125 Brescia, Italy
| | - Cristina Muscio
- IRCCS Centro San Giovanni di Dio-Fatebenefratelli, via Pilastroni 4, 20125 Brescia, Italy
| | - Marina Boccardi
- IRCCS Centro San Giovanni di Dio-Fatebenefratelli, via Pilastroni 4, 20125 Brescia, Italy
| | - Marco Lorenzi
- IRCCS Centro San Giovanni di Dio-Fatebenefratelli, via Pilastroni 4, 20125 Brescia, Italy
| | - Giovanni de Girolamo
- IRCCS Centro San Giovanni di Dio-Fatebenefratelli, via Pilastroni 4, 20125 Brescia, Italy
| | - Giovanni Frisoni
- IRCCS Centro San Giovanni di Dio-Fatebenefratelli, via Pilastroni 4, 20125 Brescia, Italy.
| |
Collapse
|
42
|
Muscio C, Boccardi M, Pievani M, Pasqualetti P, Galluzzi S, Borroni B, Padovani A, Frisoni G. P1‐171: DEMENTIA EXPERTS' PERCEIVED DIAGNOSTIC VALUE OF PET AMYLOID IMAGING. Alzheimers Dement 2014. [DOI: 10.1016/j.jalz.2014.05.409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | | | - Michela Pievani
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| | | | - Samantha Galluzzi
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| | - Barbara Borroni
- Centre for Neurodegenerative Disorders, Neurology Unit, University of BresciaBresciaItaly
| | - Alessandro Padovani
- Centre for Neurodegenerative Disorders, Neurology Unit, University of BresciaBresciaItaly
| | - Giovanni Frisoni
- Memory Clinic and LANVIE ‐ Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva ‐ Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| |
Collapse
|
43
|
Muscio C, Boccardi M, Pievani M, Pasqualetti P, Galluzzi S, Borroni B, Padovani A, Frisoni G. IC‐P‐002: DEMENTIA EXPERTS' PERCEIVED DIAGNOSTIC VALUE OF PET AMYLOID IMAGING. Alzheimers Dement 2014. [DOI: 10.1016/j.jalz.2014.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
| | | | - Michela Pievani
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| | | | - Samantha Galluzzi
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| | - Barbara Borroni
- Centre for Neurodegenerative Disorders, Neurology UnitUniversity of BresciaBresciaItaly
| | - Alessandro Padovani
- Centre for Neurodegenerative Disorders, Neurology UnitUniversity of BresciaBresciaItaly
| | - Giovanni Frisoni
- Memory Clinic and LANVIE ‐ Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva ‐ Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| |
Collapse
|
44
|
Muscio C, Boccardi M, Guerra UP, Paghera B, Pizzocaro C, Pievani M, Padovani A, Frisoni G. THE INCREMENTAL DIAGNOSTIC VALUE OF 18F‐FLORBETAPIR IMAGING IN NATURALISTIC PATIENTS WITH COGNITIVE IMPAIRMENT: THE INDIA‐FBP STUDY. Alzheimers Dement 2014. [DOI: 10.1016/j.jalz.2014.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
| | | | | | - Barbara Paghera
- University of Brescia and Spedali Civili di BresciaBresciaItaly
| | | | - Michela Pievani
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| | - Alessandro Padovani
- Centre for Neurodegenerative Disorders, Neurology UnitUniversity of BresciaBresciaItaly
| | - Giovanni Frisoni
- Memory Clinic and LANVIE ‐ Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva ‐ Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| |
Collapse
|
45
|
Muscio C, Boccardi M, Guerra UP, Paghera B, Pizzocaro C, Pievani M, Padovani A, Frisoni G. P1‐172: THE INCREMENTAL DIAGNOSTIC VALUE OF 18F‐FLORBETAPIR IMAGING IN NATURALISTIC PATIENTS WITH COGNITIVE IMPAIRMENT: THE INDIA‐FBP STUDY. Alzheimers Dement 2014. [DOI: 10.1016/j.jalz.2014.05.410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
| | | | | | - Barbara Paghera
- University of Brescia and Spedali Civili di BresciaBresciaItaly
| | | | - Michela Pievani
- Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| | - Alessandro Padovani
- Centre for Neurodegenerative Disorders, Neurology Unit, University of BresciaBresciaItaly
| | - Giovanni Frisoni
- Memory Clinic and LANVIE ‐ Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva ‐ Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio Fatebenefratelli, The National Center for Research and Care of Alzheimer's and Mental DiseasesBresciaItaly
| |
Collapse
|